Zhitong Finance App News, Changchun Hi-Tech (000661.SZ) issued an announcement. Recently, the company's subsidiary Changchun Jinsai Pharmaceutical Co., Ltd. (“Jinsai Pharmaceutical”) received a written notice from the US Food and Drug Administration (“FDA”), and Jinsai Pharmaceutical's injectable GenSci143 clinical trial application was approved

Zhitongcaijing · 11/13/2025 12:49
Zhitong Finance App News, Changchun Hi-Tech (000661.SZ) issued an announcement. Recently, the company's subsidiary Changchun Jinsai Pharmaceutical Co., Ltd. (“Jinsai Pharmaceutical”) received a written notice from the US Food and Drug Administration (“FDA”), and Jinsai Pharmaceutical's injectable GenSci143 clinical trial application was approved